Month: November 2020

  • Top 10 Biotechnology Events in North America to Attend in 2020

    Top 10 Biotechnology Events in North America to Attend in 2020

    If you are interested in learning about new advancements in the biotech industry and grow your professional contacts, here is a list for you! These are the top events Galenvs Sciences Inc. recommends for you in 2020. See you there!

    1 BIO International Convention

    The convention will be held in San Diego, CA, USA, from June 8th to 11th, 2020, and hosted by BIO. This conference is for scientific individuals and companies coming together for the largest biotechnology event in the world to discuss the new solutions and advancements that will help grow the community and companies. Every year the BIO International Conventions have a different theme that they focus on; this year’s theme is to “Go Beyond,” the theme is to encourage the attendees to strive for their wildest dreams and to do the impossible to advance the science technologies. This event offers presentations, contests for startups, networking opportunities, exhibitions, and one-on-one partnering. Attendees can expect to have over 17,000 people from around the globe to attend, as well.

    2 Biotech Showcase

    The event will be handled on January 13th to 15th, 2020, in San Francisco, CA, USA, and co-produced by Demy Colton and EBD Group. This conference invites companies and individuals alike to learn and engage with new and developing technologies in the future of biotech. They offer many different opportunities to learn and grow, such as networking cocktails, workshops, panels, discussions, exhibitions, and presentations. When you register for this event, you should expect to have over 3,700 attendees, 2,200 companies, over 7,800 one-to-one meetings, 400 company presentations, over 1,000 investors, and people coming from over 50 countries. Also, to all the amenities, this event allows startups to present their company and grow their business with potential investors available to them all in one place.

    3 SMBE 2020

    The conference will take place in Quebec City, Quebec, Canada, from June 28th to July 2nd, 2020. The Society for Molecular Biology and Evolution Annual Conference is about bringing together biologists and scientists alike to discuss research and development from all over the world. This conference gives you access to over 1,000 evolutionary biologists and provides fantastic networking connections with an audience that is from a multitude of disciplines. The attendees can expect engaging scientific content, world-class speakers, presentations, and exhibitions.

    4 ePharma Summit

    The event will be on March 18th to 19th, 2020, in New York, New York, USA. KNect365 (soon to be Informa Connect) is the only company that hosts an event based on digital pharma dedicated to optimizing solutions to issues that will directly affect businesses, clientele, and market strategy. For 2020, they are introducing all-new content areas for case studies, discussions, and much more. The new content includes but is not limited to “digital therapeutics and practical applications currently in development,” “the advent of AI and the corresponding impact on today’s digital marketer,” and “startups currently disrupting the healthcare business and maximizing the true potential of partnerships.” In addition, this event offers over 10 hours of networking activities, such as cocktail evenings, digital experience room, scheduled intermissions, and others.

    5 MedTech Conference

    The conference will be held on October 5th to 7th, 2020, in Toronto, Ontario, Canada. MedTech is about gathering, sharing ideas, and finding new inspiration for developing new biotech technologies that will impact our future and gaining connections. The host of this event is AdvaMed, and this event brings more than 3,300 attendees together to advance business relationships and share insights on the new research. Attendees should expect to see more than 130 companies exhibiting over 100 sessions featuring more than 300 speakers covering a varies steam of subjects, and more than 2,200 meetings. At this event, there are many chances to develop connections and offer interactive sessions with the top 50 early-stage companies from the MedTech Innovator competition.

    6 BioPharm America

    The event will take place in Boston, MA, USA, from September 23rd to 24th, 2020. EBD Group and KNect365 Life Sciences host this conference. BioPharm American is about driving companies and researchers alike together to learn about improving the pharma industry and creating networks to develop. Attendees’ activities include networking, one-to-one meetings, power up partneringONE, Xcelerate Keynote Series, seminars, company presentations, and an exhibition. With the networking opportunities, there will be over 4,500 global biopharma companies to connect with and a startup pitch competition. The people attending will be 40% of senior management, 34% of top management, and 26% of middle management. Some participating investors are AIG, Ascend, Atheneos Ventures, BioIdeations, Biosense, Hillman, and many others.

    7 Molecular Genetics of Bacteria and Phages Meeting

    The event is hosted by Wisconsin Union and the date is on August 3rd to 7th, 2020. The location of the meeting is in Madison, Wisconsin, USA. This meeting is to discuss the new developments in molecular genetics and communications between companies. The sponsors of the conference of last year were American Society for Microbiology, Zymo Research, New England BioLabs Inc., Merck Inventing for Life, and National Diagnostics. The activities offered at this event is oral presentations, poster presentations, seminars, sessions with new biotech, exhibition, and other activities.

    8 Cell & Gene Therapy Bioprocessing & Commercialization

    The conference will take place from September 21st to 24th, 2020, and is located in Boston, MA, USA. KNect265 Life Sciences will host the meeting. This event is about helping connect the biotech industry to showcase the latest products and services, plus the new learning techniques. Attendees should expect to have over 50 content-driven sessions, over 250 attendees, across 14 countries represented, lots of meetings, company presentations, exhibitions, and many other activities.

    9 Next Generation Protein Therapeutics & Bioconjugates Summit

    The conference will be on June 22nd to 24th, 2020, and will be located in San Francisco, CA, USA. KNect365 hosts the meeting. This event is the 8th edition of this ever, and it is the “leading conferences in protein therapeutics, bioconjugation, and genome editing that will bring together research scientists, biologists, and bioengineers to discuss the latest breakthroughs, technologies, and discoveries in their fields,” (KNect365, 2019). This year the conference is expected to have over 350 attendees from over 20 countries. 44% of the attendees will likely be Senior Scientist /  Researchers, and 27% will be Directors. The activities will include one-on-one meetings with scientists, showcases, exhibitions, seminars, networking, and others.

    10 BioProcess International Conference & Exhibition West

    The conference will take place from March 9th to 12th, 2020, at Santa Clara, CA, USA. In addition, for the first time, BioProcess will be co-located with Cell Line Development & Engineering meeting and hosted by KNect365. The purpose of the event is to improve the efficiency, knowledge, and relationships of the attendees to push the development of the biotech industry. This year the conference’s schedule changing into a unique format, where there are eight different tracks that attendees can choose to follow based on various fields of study such as Recovery & Purification, Analytical and Quality, and others. These tracks allow people to have a unique experience and explore the seminars / presentations that fit into their field of interest. The conference is expected to have 800+ attendees, more than 75 global exhibitors, over 200 case studies / new data presentations, over 1,000 scientists, engineers, and executives.

  • Galenvs Sciences Wins Innovative Solutions Canada Phase 1 Award

    Galenvs Sciences Wins Innovative Solutions Canada Phase 1 Award

    Galenvs Sciences is pleased to announce that the company was awarded Phase 1 funding to answer one of the challenges proposed by Innovative Solutions Canada:

    Magnetic reagents for detection of COVID-19 and other RNA based molecular diagnostic kits challenge.

    Innovative Solution Canada is a program launched by Innovation, Science and Economic Development Canada (ISED), a department of the Government of Canada. This program provides funding for research and development (R&D) of Canadian companies and innovators, all with the aim of encouraging scientific advances and economic development in the country.

    Since the outbreak of the COVID-19 pandemic, the Canadian government has been working closely with the scientific industry to understand which areas require urgent investment while building domestic capabilities to fight future pandemics. As part of this effort, several companies have received or will receive funding for their R&D activities to address gaps and challenges related to COVID-19 in Canada.

    Galenvs Sciences has proven its ability to create effective solutions in the fight against COVID-19 through its various existing products, including its magnetic nanoparticle-based extraction kits and more specifically its magnetiQ Viral RNA Extraction Kit. The magnetiQ Viral RNA Extraction Kit has been validated by The National Research Council of Canada, the National Microbiology Laboratory, and has received Health Canada approval as a class II COVID-19 medical device.

    “Our government is acting quickly to ensure that we are mobilizing our innovation programming and resources to respond to the COVID-19 pandemic. The successful Made-in-Canada projects and proposals announced today will support the researchers and companies that are contributing to the fight against this pandemic. This has remained a top priority for our government and is all part of our continued commitment to protecting the health and safety of all Canadians”– The Honourable Navdeep Bains, Minister of Innovation, Science and Industry

    Galenvs Sciences is well-positioned to develop leading-edge solutions to support the national COVID-19 fight effort as the only manufacturer of magnetic nanoparticles in Canada. Based in Montreal, Galenvs specializes in magnetic nanoparticle synthesis and magnetic-based nucleic acid isolation reagent formulation informed by machine learning technology for a wide range of applications including basic and clinical research, and diagnostic procedures.

  • Galenvs annonce une entente avec le Gouvernement du Canada pour fournir les réactifs nécessaires aux tests de dépistage de la COVID-19

    Galenvs annonce une entente avec le Gouvernement du Canada pour fournir les réactifs nécessaires aux tests de dépistage de la COVID-19

    MONTRÉAL, le 23 juin 2020 – Galenvs Sciences Inc., un fournisseur de biotechnologie établi à Montréal “Galenvs”, annonce aujourd’hui que le gouvernement fédéral du Canada a signé une entente avec Galenvs pour fournir des réactifs magnétiques fonctionnalisés pour l’extraction de l’ARN du coronavirus nécessaires aux efforts de dépistage de la COVID-19 partout au Canada.

    Galenvs produit des réactifs magnétiques spécialement conçus pour les méthodes d’extraction d’ARN du coronavirus utilisées dans tous les établissements de recherche fédéraux. L’entente fait suite à une lettre d’intention adressée à Galenvs par le gouvernement du Canada pour qu’elle fournisse au gouvernement canadien du matériel clé pour le dépistage de la COVID-19.

    Basée à Montréal, au Québec, Galenvs est particulièrement bien placée pour contribuer à la réponse canadienne face à la COVID-19 en tant que seul développeur et fabricant canadien de trousses de purification et d’extraction à base magnétique alimentées par l’intelligence artificielle pour la recherche et le diagnostic cliniques et en sciences de la vie.

    « Je suis heureux de faire le point rapidement sur notre travail de développement de notre capacité de mise à l’essai et d’équipement de protection individuelle au Canada », a déclaré le ministre de l’Innovation, des Sciences et de l’Industrie, Navdeep Bains, dans un communiqué de presse publié le 17 juin 2020. « Nous avons signé un contrat avec Galenvs Sciences, à Montréal, pour la production de réactifs magnétiques, un intrant essentiel pour les tests de dépistage de la COVID-19 dans les laboratoires canadiens. »

    Le 17 juin 2020, le premier ministre canadien Justin Trudeau a également annoncé l’entente avec Galenvs dans une déclaration concernant les mesures prises pour relever les défis de la COVID-19 :

    « Nous travaillons aussi très fort pour nous assurer que les hôpitaux et les travailleurs de première ligne disposent de l’équipement et des fournitures dont ils ont besoin. Et j’ai de bonnes nouvelles à partager à ce sujet », lit-on dans la déclaration. « Notre gouvernement a signé un accord avec l’entreprise Galenvs de Montréal pour fabriquer des billes de silices qui sont essentielles au dépistage. »

    « Galenvs collabore avec l’équipe de recherche exceptionnelle du Laboratoire National de Microbiologie depuis plusieurs mois pour mettre au point une solution de réactif optimale pour l’extraction d’ARN à haut rendement », a déclaré Jamal Daoud, président de Galenvs. « Nous sommes fiers de fournir une pièce essentielle du casse-tête de l’extraction du coronavirus, et nous augmentons activement la capacité de production pour atteindre les objectifs de dépistage de la COVID-19 à grande échelle. »

    Source:

    https://www.newswire.ca/news-releases/galenvs-announces-an-agreement-with-the-government-of-canada-to-provide-reagents-required-for-covid-19-testing-891355895.html

  • Prime Minister Trudeau Mention of Galenvs Sciences in His Address to Canadians

    Prime Minister Trudeau Mention of Galenvs Sciences in His Address to Canadians

    “We are also working very hard to ensure that hospitals and front-line workers have the equipment and supplies they need. And I have some good news to share on that front. First, our government signed an agreement with Montréal-based Galenvs to produce silica beads, which are essential for testing. And this week, Health Canada also certified ventilators produced by two Canadian groups: CAE and the Ventilators for Canadians consortium.”

  • Galenvs Announces an Agreement with The Government of Canada to Provide Reagents Required for COVID-19 Testing

    Galenvs Announces an Agreement with The Government of Canada to Provide Reagents Required for COVID-19 Testing

    MONTREAL, June 23, 2020 – Montreal-based biotechnology provider Galenvs Sciences Inc. “Galenvs”, today announces that the Canadian Federal Government has signed an agreement with Galenvs to supply functionalized magnetic reagents for Coronavirus RNA extraction necessary to enable the COVID-19 testing efforts across Canada.

    Galenvs is producing magnetic-based reagents specifically designed for Coronavirus RNA extraction methodologies used in all federal research institutions. The agreement follows a Letter of Intent issued to Galenvs from The Canadian Government to supply The Canadian Government with a key material for COVID-19 testing.

    Based in Montreal, Quebec, Galenvs is uniquely positioned to help in the Canadian COVID-19 response as the only Canadian developer and manufacturer of AI-powered, magnetic-based purification and extraction kits for clinical and life sciences research & diagnostics.

    “I’m happy to provide a quick update on our work to developing testing and personal protective equipment capacity in Canada,” said Navdeep Bains, Minister of Innovation, Science and Industry, in a press update brief on June 17th, 2020. “We have signed a contract with Galenvs Sciences in Montreal for the production of magnetic reagents, which is a critical input for COVID-19 testing in Canadian labs.”

    On June 17th, 2020, Canadian Prime Minister Justin Trudeau also announced the agreement with Galenvs in a statement regarding the measures taken for the COVID-19 challenge:

    “We are also working very hard to ensure that hospitals and front-line workers have the equipment and supplies they need. And I have some good news to share on that front,” reads the statement. “[O]ur government signed an agreement with Montréal-based Galenvs to produce magnetic reagents, which are essential for testing.”

    “Galenvs has been working hand-in-hand with the exceptional research team at the National Microbiology Laboratory for several months to develop an optimal reagent solution for high-yield RNA extraction,” said Jamal Daoud, President of Galenvs. “We are proud to supply an essential piece of the Coronavirus extraction puzzle, and we’re actively ramping up production capacity to meet the large scale COVID-19 testing objectives.”

    Source:

    https://www.newswire.ca/news-releases/galenvs-announces-an-agreement-with-the-government-of-canada-to-provide-reagents-required-for-covid-19-testing-891355895.html